weight loss glp 1 agonists GLP-1 Medications for Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness Managing Side Effects of GLP-1

Expected Weight Loss: In the head-to-head SURMOUNT-5 trial published in The New England Journal of Medicine , tirzepatide was shown to be superior to semaglutide for reduction in body weight and waist circumference at 72 weeks among adults with obesity (without diabetes)

Which is more effective for weight loss, semaglutide GLP-1 or Zepbound

Thirdly, GLP-1 agonists slow gastric emptying, leading to a delayed absorption of nutrients and a prolonged feeling of fullness, which can contribute to reduced food intake and weight loss

compared to a low bioavailability of 1-2% when taken orally

N Engl J Med 389:2221-32

In 2023, Eli Lilly entered the market with Zepbound (tirzepatide), boasting over 20% weight loss at 72 weeks and a slightly lower price